SurgiQuest develops, manufactures and markets access technologies for minimally invasive surgery, notably the AirSeal System. The AirSeal System provides access to the abdominal cavity during minimally invasive surgery (MIS). The company intends to use recently raised capital to expand organizational capabilities and increase global adoption of the AirSeal System. SurgiQuest closed a combined $18.5m equity and debt financing in late September 2012. The financing supports the company’s commercialization and expansion efforts. SurgiQuest was founded in May 2006 by Kurt Azarbarzin and is based in Milford, Conn. SurgiQuest develops, manufactures and markets access technology for minimally invasive surgery from Orange, Connecticut. Its patented AirSeal® Access System provides access to the abdominal cavity during minimally invasive procedures. The system is designed to assure stable pneumoperitoneum, evacuate smoke and plume when electrocautery, laser or ultrasound devices are used, and to provide valve-free access during both laparoscopic and robotic procedures. Founded in May 2006 by CEO Kurt Azarbarzin, the company focuses on innovative access solutions for surgery. SurgiQuest closed a $19M financing round in September 2011 and plans to use the funds to expand its sales efforts domestically and abroad.

Total raised

$38M

Funding rounds

3

Latest round

Series D

Latest activity

Dec 2012